fluconazole has been researched along with Developmental Disabilities in 8 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluconazole prophylaxis for the prevention of invasive Candida infections is safe in extremely low birth weight infants and does not appear to be associated with any long-term adverse effects on neurodevelopment and quality of life at 8 to 10 years of life." | 5.15 | Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. ( Boyle, R; Cuff, AL; Grossman, LB; Gurka, MJ; Kaufman, DA; Patrick, P; Wamstad, JB, 2011) |
| " Two trials compared different dosing regimens of prophylactic intravenous fluconazole." | 2.44 | Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. ( Austin, N; Clerihew, L; McGuire, W, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, N | 5 |
| McGuire, W | 5 |
| Cleminson, J | 1 |
| Kaufman, DA | 1 |
| Cuff, AL | 1 |
| Wamstad, JB | 1 |
| Boyle, R | 1 |
| Gurka, MJ | 1 |
| Grossman, LB | 1 |
| Patrick, P | 1 |
| Clerihew, L | 3 |
| Benjamin, DK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| DURATION OF TIME OUTSIDE, BELOW, AND ABOVE THE TARGETED Oxygen SATURATION RANGE In Preterm Infants[NCT00845624] | 102 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for fluconazole and Developmental Disabilities
| Article | Year |
|---|---|
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Topics: Antifungal Agents; Developmental Disabilities; Fluconazole; Humans; Infant, Newborn; Infant, Very Lo | 2013 |
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Topics: Antifungal Agents; Developmental Disabilities; Fluconazole; Humans; Infant, Newborn; Infant, Prematu | 2015 |
Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Topics: Antifungal Agents; Developmental Disabilities; Fluconazole; Hospital Mortality; Humans; Infant, Newb | 2003 |
Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Topics: Antifungal Agents; Developmental Disabilities; Fluconazole; Hospital Mortality; Humans; Infant, Newb | 2004 |
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Topics: Antifungal Agents; Developmental Disabilities; Fluconazole; Hospital Mortality; Humans; Infant, Newb | 2007 |
1 trial available for fluconazole and Developmental Disabilities
| Article | Year |
|---|---|
Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
Topics: Antifungal Agents; Candidiasis; Child; Developmental Disabilities; Double-Blind Method; Female; Fluc | 2011 |
2 other studies available for fluconazole and Developmental Disabilities
| Article | Year |
|---|---|
Seven days in medicine: 2-8 January.
Topics: Abortion, Spontaneous; Alcoholic Beverages; Anti-Bacterial Agents; Antifungal Agents; Cardiomyopathi | 2016 |
First, do no harm.
Topics: Antifungal Agents; Candidiasis; Developmental Disabilities; Female; Fluconazole; Humans; Incidence; | 2008 |